4//SEC Filing
Nabulsi Azmi 4
Accession 0001209191-22-031090
CIK 0001783183other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 5:19 PM ET
Size
6.4 KB
Accession
0001209191-22-031090
Insider Transaction Report
Form 4
Nabulsi Azmi
Chief Operating Officer
Transactions
- Award
Common Stock
2022-05-19+12,000→ 33,378 total
Holdings
- 843.42(indirect: By 401(k))
Common Stock
- 785,700(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Represents restricted stock units ("RSUs") granted on May 19, 2022. One third (1/3) of the total number of RSUs granted vest on November 19, 2022, May 19, 2023 and November 19, 2023, subject to the Reporting Person's continued service on each applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001791412
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 5:19 PM ET
- Size
- 6.4 KB